ARGENT BIOPHARMA LIMITED - Announcements

Market Cap $14.52M Add to my watchlist

Healthcare

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug... Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.More

RCE'S BREAKTHROUGH

Synthetic anti-infective developer Recce Pharmaceuticals Ltd (ASX:RCE) has made inroads for recognition of its RECCE® 327 Gel (or R327G) as a topical treatment for burn wound infections, gaining a US$2 million grant from the US Department of Defense...

Announcements

Filter Results

All Price Sensitive Only

RGT	Proposed issue of securities - MXC		14/07/23	29.44KB	Share
RGT	Commitments Received for GBP 0.7m	PRICE SENSITIVE	14/07/23	482.3KB	Share
RGT	Clarification Announcement		12/07/23	218.93KB	Share
RGT	AMC Places Second Order of ArtemiC for US$1M	PRICE SENSITIVE	07/07/23	242.11KB	Share
RGT	MGC Welcomes Reclassification of Psychedelic Compounds		03/07/23	194.7KB	Share
RGT	Details of Company Address		30/06/23	222.41KB	Share
RGT	Company Update		30/06/23	208.34KB	Share
RGT	Results of Meeting		29/06/23	464.39KB	Share
RGT	s708A(5)(e) Cleansing Notice		21/06/23	228.64KB	Share
RGT	Application for quotation of securities - MXC		21/06/23	25.09KB	Share
RGT	Final Director's Interest Notice x 2		01/06/23	432.88KB	Share
RGT	Initial Director's Interest Notice		01/06/23	198.4KB	Share
RGT	Appointment of Non-Executive Director		01/06/23	211.57KB	Share
RGT	First CannEpil Delivered to UK Patients		31/05/23	276.98KB	Share
RGT	Corporate Update - Board and UK Adviser Changes		30/05/23	213.92KB	Share
RGT	Notice of General Meeting/Proxy Form		30/05/23	451.38KB	Share
RGT	Distribution of General Meeting Documents - Notice of Access		30/05/23	240.39KB	Share
RGT	Change in Director's Interests x 5		05/05/23	817.3KB	Share
RGT	s708A(5)(e) Cleansing Notice		05/05/23	250.89KB	Share
RGT	Application for quotation of securities - MXC		05/05/23	25.6KB	Share
RGT	Application for quotation of securities - MXC		05/05/23	27.29KB	Share
RGT	Notification regarding unquoted securities - MXC		05/05/23	23.65KB	Share
RGT	Notification of cessation of securities - MXC		05/05/23	22.21KB	Share
RGT	Malta Production Facility Receives EU-GMP Approval	PRICE SENSITIVE	02/05/23	252.9KB	Share
RGT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	598.45KB	Share
RGT	s708A(5)(e) Cleansing Notice		20/04/23	250.6KB	Share
RGT	Notification regarding unquoted securities - MXC		20/04/23	28.66KB	Share
RGT	Application for quotation of securities - MXC		20/04/23	24.87KB	Share
RGT	Becoming a substantial holder		18/04/23	154.65KB	Share
RGT	s708A(5)(e) Cleansing Notice		14/04/23	264.5KB	Share
RGT	Application for quotation of securities - MXC		14/04/23	24.92KB	Share
RGT	Proposed issue of securities - MXC		13/04/23	28KB	Share
RGT	Proposed issue of securities - MXC		13/04/23	28.3KB	Share
RGT	Fundraise closed raising up to a total of GBP 2.09m	PRICE SENSITIVE	13/04/23	352.17KB	Share
RGT	CannEpil now available by Named Patient Request in UK	PRICE SENSITIVE	11/04/23	282.24KB	Share
RGT	MGC Pharma Investor Presentation April 2023		11/04/23	6.14MB	Share
RGT	Funding Commitments Received for GBP 1.8m	PRICE SENSITIVE	11/04/23	580.07KB	Share
RGT	Trading Halt	PRICE SENSITIVE	11/04/23	583.48KB	Share
RGT	MGC Receive Permission for Psilocybin Research & Development	PRICE SENSITIVE	03/04/23	243.11KB	Share
RGT	Notification of cessation of securities - MXC		03/04/23	22.17KB	Share
RGT	Results of Meeting		30/03/23	511.15KB	Share
RGT	ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order	PRICE SENSITIVE	21/03/23	281.01KB	Share
RGT	First patient enrolled in MGC ZAM App CannEpil Trial		15/03/23	215.13KB	Share
RGT	Notification regarding unquoted securities - MXC		09/03/23	23.66KB	Share
RGT	Provision of US$500,000 Funding		08/03/23	223KB	Share
RGT	s708A(12C)(e) Cleansing Notice		08/03/23	315.05KB	Share
RGT	Proposed issue of securities - MXC		08/03/23	24.56KB	Share
RGT	Completion of CimetrA Mechanism of Action study	PRICE SENSITIVE	07/03/23	324.77KB	Share
RGT	Appointment of UK Lead Broker Change of Company Secretary		01/03/23	219.47KB	Share
RGT	s708A(5)(e) Cleansing Notice		28/02/23	277.23KB	Share
RGT	Application for quotation of securities - MXC		28/02/23	25.16KB	Share
RGT	Half Year Accounts	PRICE SENSITIVE	28/02/23	762.24KB	Share
RGT	Notice of General Meeting/Proxy Form		28/02/23	412.29KB	Share
RGT	Distribution of General Meeting Documents - Notice of Access		28/02/23	323.5KB	Share
RGT	Investor Presentation		10/02/23	4.09MB	Share
RGT	Notification regarding unquoted securities - MXC		06/02/23	25.34KB	Share
RGT	Provision of US$600,000 Funding and change of CFO	PRICE SENSITIVE	03/02/23	203.44KB	Share
RGT	s708A(12C)(e) Cleansing Notice		02/02/23	365.96KB	Share
RGT	Proposed issue of securities - MXC		02/02/23	26.21KB	Share
RGT	Proposed issue of securities - MXC		02/02/23	24.56KB	Share
RGT	Refinancing and Extension to Convertible Security Agreements	PRICE SENSITIVE	02/02/23	215.36KB	Share
RGT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/23	1.55MB	Share
RGT	Change of External Financial Auditor		11/01/23	216.03KB	Share
RGT	Results of CimetrA bioanalytics pre-clinal trial	PRICE SENSITIVE	10/01/23	349.88KB	Share
RGT	Final Director's Interest Notice		03/01/23	273.79KB	Share
RGT	Internal Costs Review Completed and Board Change	PRICE SENSITIVE	03/01/23	249.35KB	Share
RGT	Notification regarding unquoted securities - MXC		29/12/22	23.67KB	Share
RGT	Proposed issue of securities - MXC		23/12/22	23.84KB	Share
RGT	s708A(12)(e) Cleansing Notice		23/12/22	464.34KB	Share
RGT	$800,000 of funding received through Mercer Facility	PRICE SENSITIVE	23/12/22	235.46KB	Share
RGT	Completion of CimetrA Efficacy Pre-clinical Trial	PRICE SENSITIVE	07/12/22	224.62KB	Share
RGT	US$1,000,000 ArtemiC order delivered to US partner, AMC	PRICE SENSITIVE	05/12/22	269.38KB	Share
RGT	Publication of Peer Reviewed Glioblastoma Research	PRICE SENSITIVE	02/12/22	363.02KB	Share
RGT	Results of Meeting		25/11/22	261.35KB	Share
RGT	Investor Presentation		25/11/22	7.1MB	Share
RGT	AGM Webcast Registration Instructions		17/11/22	174.53KB	Share
RGT	s708A(5)(e) Cleansing Notice		01/11/22	211.18KB	Share
RGT	Application for quotation of securities - MXC		01/11/22	25.11KB	Share
RGT	Application for quotation of securities - MXC		01/11/22	25.61KB	Share
RGT	Notification regarding unquoted securities - MXC		01/11/22	23.66KB	Share
RGT	s708A(12C)(e) Cleansing Notice		01/11/22	374.48KB	Share
RGT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	397.63KB	Share
RGT	Proposed issue of securities - MXC		28/10/22	24.08KB	Share
RGT	Dispatch of 2022 Annual General Meeting documents		25/10/22	631.54KB	Share
RGT	Long COVID study Results	PRICE SENSITIVE	25/10/22	496.19KB	Share
RGT	Trading Halt	PRICE SENSITIVE	24/10/22	978.04KB	Share
RGT	Pause in Trading	PRICE SENSITIVE	24/10/22	116.1KB	Share
RGT	Operations Update	PRICE SENSITIVE	20/10/22	237.39KB	Share
RGT	Annual Report to shareholders		18/10/22	4.06MB	Share
RGT	Notice of Annual General Meeting/Proxy Form		18/10/22	606.93KB	Share
RGT	Results of Meeting		06/10/22	277.17KB	Share
RGT	Appointment of UK Corporate Advisor and Company Update	PRICE SENSITIVE	04/10/22	906.45KB	Share
RGT	Appendix 4G Corporate Governance Key Disclosures		03/10/22	278.98KB	Share
RGT	Full Year Statutory Accounts		03/10/22	1.16MB	Share
RGT	TGA advertising Infringement Notice	PRICE SENSITIVE	28/09/22	169.23KB	Share
RGT	Notification regarding unquoted securities - MXC		23/09/22	23.65KB	Share
RGT	US$550,000 Convertible Note Facility Funding	PRICE SENSITIVE	23/09/22	216.97KB	Share
RGT	s708A(12C)(e) Cleansing Notice		21/09/22	391.69KB	Share
RGT	Proposed issue of securities - MXC		21/09/22	24.4KB	Share
RGT	Interim Results - CimetrA Dosing Finding Study	PRICE SENSITIVE	21/09/22	280.99KB	Share

RGT Proposed issue of securities - MXC
14/07/23		29.44KB	Share
RGT Commitments Received for GBP 0.7m
14/07/23	PRICE SENSITIVE	482.3KB	Share
RGT Clarification Announcement
12/07/23		218.93KB	Share
RGT AMC Places Second Order of ArtemiC for US$1M
07/07/23	PRICE SENSITIVE	242.11KB	Share
RGT MGC Welcomes Reclassification of Psychedelic Compounds
03/07/23		194.7KB	Share
RGT Details of Company Address
30/06/23		222.41KB	Share
RGT Company Update
30/06/23		208.34KB	Share
RGT Results of Meeting
29/06/23		464.39KB	Share
RGT s708A(5)(e) Cleansing Notice
21/06/23		228.64KB	Share
RGT Application for quotation of securities - MXC
21/06/23		25.09KB	Share
RGT Final Director's Interest Notice x 2
01/06/23		432.88KB	Share
RGT Initial Director's Interest Notice
01/06/23		198.4KB	Share
RGT Appointment of Non-Executive Director
01/06/23		211.57KB	Share
RGT First CannEpil Delivered to UK Patients
31/05/23		276.98KB	Share
RGT Corporate Update - Board and UK Adviser Changes
30/05/23		213.92KB	Share
RGT Notice of General Meeting/Proxy Form
30/05/23		451.38KB	Share
RGT Distribution of General Meeting Documents - Notice of Access
30/05/23		240.39KB	Share
RGT Change in Director's Interests x 5
05/05/23		817.3KB	Share
RGT s708A(5)(e) Cleansing Notice
05/05/23		250.89KB	Share
RGT Application for quotation of securities - MXC
05/05/23		25.6KB	Share
RGT Application for quotation of securities - MXC
05/05/23		27.29KB	Share
RGT Notification regarding unquoted securities - MXC
05/05/23		23.65KB	Share
RGT Notification of cessation of securities - MXC
05/05/23		22.21KB	Share
RGT Malta Production Facility Receives EU-GMP Approval
02/05/23	PRICE SENSITIVE	252.9KB	Share
RGT Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	598.45KB	Share
RGT s708A(5)(e) Cleansing Notice
20/04/23		250.6KB	Share
RGT Notification regarding unquoted securities - MXC
20/04/23		28.66KB	Share
RGT Application for quotation of securities - MXC
20/04/23		24.87KB	Share
RGT Becoming a substantial holder
18/04/23		154.65KB	Share
RGT s708A(5)(e) Cleansing Notice
14/04/23		264.5KB	Share
RGT Application for quotation of securities - MXC
14/04/23		24.92KB	Share
RGT Proposed issue of securities - MXC
13/04/23		28KB	Share
RGT Proposed issue of securities - MXC
13/04/23		28.3KB	Share
RGT Fundraise closed raising up to a total of GBP 2.09m
13/04/23	PRICE SENSITIVE	352.17KB	Share
RGT CannEpil now available by Named Patient Request in UK
11/04/23	PRICE SENSITIVE	282.24KB	Share
RGT MGC Pharma Investor Presentation April 2023
11/04/23		6.14MB	Share
RGT Funding Commitments Received for GBP 1.8m
11/04/23	PRICE SENSITIVE	580.07KB	Share
RGT Trading Halt
11/04/23	PRICE SENSITIVE	583.48KB	Share
RGT MGC Receive Permission for Psilocybin Research & Development
03/04/23	PRICE SENSITIVE	243.11KB	Share
RGT Notification of cessation of securities - MXC
03/04/23		22.17KB	Share
RGT Results of Meeting
30/03/23		511.15KB	Share
RGT ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order
21/03/23	PRICE SENSITIVE	281.01KB	Share
RGT First patient enrolled in MGC ZAM App CannEpil Trial
15/03/23		215.13KB	Share
RGT Notification regarding unquoted securities - MXC
09/03/23		23.66KB	Share
RGT Provision of US$500,000 Funding
08/03/23		223KB	Share
RGT s708A(12C)(e) Cleansing Notice
08/03/23		315.05KB	Share
RGT Proposed issue of securities - MXC
08/03/23		24.56KB	Share
RGT Completion of CimetrA Mechanism of Action study
07/03/23	PRICE SENSITIVE	324.77KB	Share
RGT Appointment of UK Lead Broker Change of Company Secretary
01/03/23		219.47KB	Share
RGT s708A(5)(e) Cleansing Notice
28/02/23		277.23KB	Share
RGT Application for quotation of securities - MXC
28/02/23		25.16KB	Share
RGT Half Year Accounts
28/02/23	PRICE SENSITIVE	762.24KB	Share
RGT Notice of General Meeting/Proxy Form
28/02/23		412.29KB	Share
RGT Distribution of General Meeting Documents - Notice of Access
28/02/23		323.5KB	Share
RGT Investor Presentation
10/02/23		4.09MB	Share
RGT Notification regarding unquoted securities - MXC
06/02/23		25.34KB	Share
RGT Provision of US$600,000 Funding and change of CFO
03/02/23	PRICE SENSITIVE	203.44KB	Share
RGT s708A(12C)(e) Cleansing Notice
02/02/23		365.96KB	Share
RGT Proposed issue of securities - MXC
02/02/23		26.21KB	Share
RGT Proposed issue of securities - MXC
02/02/23		24.56KB	Share
RGT Refinancing and Extension to Convertible Security Agreements
02/02/23	PRICE SENSITIVE	215.36KB	Share
RGT Quarterly Activities/Appendix 4C Cash Flow Report
30/01/23	PRICE SENSITIVE	1.55MB	Share
RGT Change of External Financial Auditor
11/01/23		216.03KB	Share
RGT Results of CimetrA bioanalytics pre-clinal trial
10/01/23	PRICE SENSITIVE	349.88KB	Share
RGT Final Director's Interest Notice
03/01/23		273.79KB	Share
RGT Internal Costs Review Completed and Board Change
03/01/23	PRICE SENSITIVE	249.35KB	Share
RGT Notification regarding unquoted securities - MXC
29/12/22		23.67KB	Share
RGT Proposed issue of securities - MXC
23/12/22		23.84KB	Share
RGT s708A(12)(e) Cleansing Notice
23/12/22		464.34KB	Share
RGT $800,000 of funding received through Mercer Facility
23/12/22	PRICE SENSITIVE	235.46KB	Share
RGT Completion of CimetrA Efficacy Pre-clinical Trial
07/12/22	PRICE SENSITIVE	224.62KB	Share
RGT US$1,000,000 ArtemiC order delivered to US partner, AMC
05/12/22	PRICE SENSITIVE	269.38KB	Share
RGT Publication of Peer Reviewed Glioblastoma Research
02/12/22	PRICE SENSITIVE	363.02KB	Share
RGT Results of Meeting
25/11/22		261.35KB	Share
RGT Investor Presentation
25/11/22		7.1MB	Share
RGT AGM Webcast Registration Instructions
17/11/22		174.53KB	Share
RGT s708A(5)(e) Cleansing Notice
01/11/22		211.18KB	Share
RGT Application for quotation of securities - MXC
01/11/22		25.11KB	Share
RGT Application for quotation of securities - MXC
01/11/22		25.61KB	Share
RGT Notification regarding unquoted securities - MXC
01/11/22		23.66KB	Share
RGT s708A(12C)(e) Cleansing Notice
01/11/22		374.48KB	Share
RGT Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	397.63KB	Share
RGT Proposed issue of securities - MXC
28/10/22		24.08KB	Share
RGT Dispatch of 2022 Annual General Meeting documents
25/10/22		631.54KB	Share
RGT Long COVID study Results
25/10/22	PRICE SENSITIVE	496.19KB	Share
RGT Trading Halt
24/10/22	PRICE SENSITIVE	978.04KB	Share
RGT Pause in Trading
24/10/22	PRICE SENSITIVE	116.1KB	Share
RGT Operations Update
20/10/22	PRICE SENSITIVE	237.39KB	Share
RGT Annual Report to shareholders
18/10/22		4.06MB	Share
RGT Notice of Annual General Meeting/Proxy Form
18/10/22		606.93KB	Share
RGT Results of Meeting
06/10/22		277.17KB	Share
RGT Appointment of UK Corporate Advisor and Company Update
04/10/22	PRICE SENSITIVE	906.45KB	Share
RGT Appendix 4G Corporate Governance Key Disclosures
03/10/22		278.98KB	Share
RGT Full Year Statutory Accounts
03/10/22		1.16MB	Share
RGT TGA advertising Infringement Notice
28/09/22	PRICE SENSITIVE	169.23KB	Share
RGT Notification regarding unquoted securities - MXC
23/09/22		23.65KB	Share
RGT US$550,000 Convertible Note Facility Funding
23/09/22	PRICE SENSITIVE	216.97KB	Share
RGT s708A(12C)(e) Cleansing Notice
21/09/22		391.69KB	Share
RGT Proposed issue of securities - MXC
21/09/22		24.4KB	Share
RGT Interim Results - CimetrA Dosing Finding Study
21/09/22	PRICE SENSITIVE	280.99KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 30.0¢		Change 0.000(0.00%)		Mkt cap ! $14.52M

Open	High	Low	Value	Volume
28.5¢	30.0¢	28.5¢	$290	1.008K

Buyers (Bids)

No.	Vol.	Price($)
1	1456	29.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.0¢	2307	1

View Market Depth

No.	Vol.	Price($)
1	1456	0.290
1	3376	0.285
1	3295	0.280
3	23700	0.270
2	9500	0.260

Price($)	Vol.	No.
0.300	2307	1
0.305	15833	3
0.310	1492	1
0.315	2825	2
0.340	2115	2

Last trade - 16.10pm 19/07/2024 (20 minute delay)

RGT (ASX) Chart

ARGENT BIOPHARMA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories